Figure 2.
Risk ratio of neuropsychiatric symptoms with tafenoquine as compared to placebo or a control group. Figure 2(a). Any reported neurological adverse effect. (b). Any reported psychiatric adverse effect.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.